Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Mechanism MRC2 antagonists(C-type mannose receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ADCendo ApSStartup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteosarcoma | Preclinical | US | 15 Jun 2022 | |
Osteosarcoma | Preclinical | DK | ADCendo ApSStartup | 15 Jun 2022 |